Mabion is a Biologics CDMO Leadership Award Europe Finalist
- Mabion has been recognized as the Finalist of the 2025 International CDMO Leadership Awards for Biologics.
- Mabion emerged as a leader in the Biologics – International category, demonstrating its commitment to high standards and customer satisfaction.
This year’s edition of the awards represents the first European celebration of CDMO achievement, hosted at CPHI Frankfurt – the largest and most influential EU gathering in the global biopharma industry. For more than a decade, the CDMO Leadership Awards have stood as one of the sector’s most prestigious honors, highlighting organizations that excel in performance, innovation, and partnership.
Our recognition stems from the depth and breadth of Mabion’s end-to-end biologics development and manufacturing capabilities. With integrated expertise across cell line development, process optimization, large-scale manufacturing, and fill-finish operations, Mabion provides its partners with reliable, science-driven solutions that shorten timelines and ensure product quality.
Winners and finalists will be celebrated on October 28, 2025, at the Steigenberger Hof Hotel in Frankfurt, during a dedicated Awards Ceremony and Reception, followed by Orientation Marketing’s 10th Anniversary Afterparty. This event not only honors today’s CDMO leaders but also highlights the role of scientific excellence, sustainable practices, and innovation in shaping the future of biopharmaceutical manufacturing. Mabion is proud to stand among the organizations driving these standards forward, reinforcing our mission to be a trusted partner in advancing life-changing biologics.
Outsourced Pharma is proud to host our CDMO Leadership Awards in Europe for the first time in our history of over a decade. The 2025 CDMO Leadership Awards Europe is a well-deserved recognition to European organizations that have demonstrated excellence in contract development and manufacturing. These awards are the most important in our industry because they are based on the judgement of biopharma sponsors and the value they place in trusted partnerships.
Being a Finalist in CDMO for Biologics category underscores our unwavering commitment to excellence, reliability, and scientific innovation. It is a confirmation to the trust our partners place in us and our relentless pursuit of delivering high-quality CDMO solutions that help bring breakthrough biologics to market.
We also extend our congratulations to all the other finalists who continue to shape the future of the CDMO industry.
For more information about Mabion’s capabilities as an International CDMO for Biologics, check out our services.
About the CDMO Leadership Awards
The CDMO Leadership Awards are presented by Outsourced Pharma and Life Science Connect. Winners are selected based on primary research conducted by Orientation Marketing, reflecting direct feedback from biopharmaceutical professionals who have recently partnered with CDMOs. The awards recognize contract development and manufacturing organizations that deliver excellence in quality, capabilities, expertise, reliability, compatibility, and service. Learn more at www.cmoleadershipawards.com.
About Life Science Connect
Life Science Connect is a network of trusted online communities, including Clinical Leader, Outsourced Pharma, Bioprocess Online, Cell & Gene, and others, dedicated to helping industry professionals make informed decisions and build valuable partnerships. Through expert editorial content and innovative commercial solutions, LSC connects biopharma professionals with suppliers who can help advance development and manufacturing programs.
Prepared by:
Jakub Knurek
Marketing Specialist